GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q1 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $160.4 million versus the consensus estimate of $160.58 million.

GUIDANCE:

GoodRx Holdings, Inc. sees Q2 2021 revenue of $172-176 million, versus the consensus of $172.4 million.

GoodRx Holdings, Inc. sees FY2021 revenue of $740-760 million, versus the consensus of $748.4 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.